Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease
Open Access
- 3 January 2026
- journal article
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 20, 94-100
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 46 references indexed in Scilit:
- Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative reviewAgeing Research Reviews, 2024
- Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer's disease pathologyNeurobiology of Aging, 2021
- Essential role of hippocampal noradrenaline in the regulation of spatial working memory and TDP‐43 tissue pathologyJournal of Comparative Neurology, 2018
- Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's diseaseNeurobiology of Aging, 2014
- Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disordersPharmacology Biochemistry and Behavior, 2011
- The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2011
- The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s diseaseJournal of Bioenergetics and Biomembranes, 2009
- Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: Evidence of compensatory changesNeuroscience, 2007
- Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine releaseNeuropharmacology, 2005
- Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's diseaseJournal of Neural Transmission, 2003